Every day, in operating rooms around the world, surgeons are faced with challenging repairs and reconstructions of soft tissues in cancer, trauma, diabetic, burn, and sports medicine patients. For their most challenging repairs, surgeons choose TEI Biosciences’ novel biologic products for superior clinical outcomes.
Bovine vs Porcine Acellular Dermal Matrix for Complex Abdominal Wall Reconstruction.
American Society of Plastic and Reconstructive Surgery Learn More
Improvement of Success Rates for Abdominal Component Reconstructions Using Bovine Fetal Collagen
Annals of Plastic Surgery Learn More
A Case Study
Acellular Bovine-Derived Matrix Used on a Traumatic Crush Injury of the Hand
Ostomy Wound Management Learn More
News + Events
June 13, 2013
June 5, 2013
TEI Biosciences Inc. (“TEI”) announced today that it was granted full approval by FDA’s Center for Devices and Radiological Health to initiate a human clinical trial to gain specific claims of clinical benefits from use of SurgiMend® PRS in breast reconstruction following mastectomy for breast cancer.